Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)

PHASE3CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

July 31, 2003

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Tiotropium

DEVICE

Respimat SMI

DEVICE

HandiHaler

Trial Locations (2)

Unknown

Boehringer Ingelheim Investigational Site, Study Chairs Or Principal Investigators

Boehringer Ingelheim Investigational Site, Study Chairs Or Principal Investigators

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00281567 - Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter